|
S. aureus
220 | MSSA 55% (121/220) | MRSA 45% (99/220) | hVISA 5.5% (12/220) |
---|
MIC50/90 | 1/2 | 1/2 (p = 0.51)a
| 1/2 (p = 0.46)a
| 1.5/2 (p = 0.03)a
|
agr-dysfunction | 15% (33/220) | 10% (12/121) | 21% (21/99) (p = 0.02)b
| 58% (7/12) (p< 0.0005)c
|
- MIC50/90 determined by CLSI broth microdilution and the prevalence of agr-dysfunctional
-
a MIC distribution of total clinical S.aureus versus MIC distribution of each phenotype (Mann-Whitney U)
-
b Prevalence of agr dysfunction in MRSA isolates versus MSSA isolates (Chi-square test)
-
c Prevalence of agr dysfunction in hVISA isolates versus VSSA isolates (Chi-square test)